Clinical Trials
98 trialsNeoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
STARS
University of Utah
Virtual Sun Safe Workplaces Ph II (SSW Works)
Klein Buendel, Inc.
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
COLUMBUS
Pfizer
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
At-Home Dermoscopy Artificial Intelligence
OHSU Knight Cancer Institute
Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...
National Institutes of Health Clinical Center (CC)
Ipilimumab With Lymphodepletion Plus Adoptive Cell Transfer and High Dose IL-2 in Melanoma Mets Pts
H. Lee Moffitt Cancer Center and Research Institute
Using MC1R Genotype to Impact Melanoma Risk Behavior
H. Lee Moffitt Cancer Center and Research Institute
COMBI-i
Novartis
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Verrica Pharmaceuticals Inc.
PROSKIN
Charite University, Berlin, Germany
CheckMate-6GE
Bristol-Myers Squibb
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Indiana University
SOMBRA
University of New Mexico
Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen
Yale University
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
University of Arizona
RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction
Avita Medical
VISTA
Enspectra Health
SpotCheck: Comparison of Enhanced Telemedicine Versus In-person Evaluation for the Diagnosis of Skin Cancer
NYU Langone Health
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
Apexigen America, Inc.
VISION
Enspectra Health
OASIS
Cardiff and Vale University Health Board
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Rutgers, The State University of New Jersey
PROCLIVITY02
Clinigen, Inc.
Using Physical Tracking to Predict Sunburn
Klein Buendel, Inc.
UV Exposure Assessed With Wearable Sensor and Sun Protection
Northwestern University
Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC
Revolution Medicines, Inc.
Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
Dana-Farber Cancer Institute
PIVOT-12
Nektar Therapeutics
Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
H. Lee Moffitt Cancer Center and Research Institute
A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma
Idera Pharmaceuticals, Inc.
Study of ADI-PEG 20 in Patients With Advanced Melanoma
Ludwig Institute for Cancer Research
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
University Hospitals Cleveland Medical Center
Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma
Novartis
Social Media Indoor Tanning Study
University of Connecticut
SYNERGY-001
Dynavax Technologies Corporation
An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma
Bristol-Myers Squibb
VAKCCT
VA Office of Research and Development
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
University of California, San Francisco
Post Excision/Mohs Scar Laser Resurfacing
Icahn School of Medicine at Mount Sinai
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Pfizer
PDT
University of Sao Paulo
Preventing Squamous Cell Skin Cancer
University of Rochester
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
Massachusetts Eye and Ear Infirmary
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
Weill Medical College of Cornell University
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
National Institutes of Health Clinical Center (CC)
Lapatinib in Stage IV Melanoma With ERBB4 Mutations
National Institutes of Health Clinical Center (CC)